|Bid||1.8800 x 1200|
|Ask||2.5000 x 1100|
|Day's range||2.0200 - 2.1000|
|52-week range||1.4900 - 6.1900|
|Beta (5Y monthly)||1.84|
|PE ratio (TTM)||N/A|
|Earnings date||07 May 2020 - 11 May 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||12 Dec 2019|
|1y target est||4.00|
Anyone researching Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) might want to consider the historical volatility of...
As the US$72m market cap Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) released another year of negative earnings...
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! It is a pleasure to report that the Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is up 58% in the last quarter. But...